市場調查報告書
商品編碼
1472990
研究抗體和試劑市場評估:依產品、技術、應用、最終用戶和地區劃分的機會和預測(2017-2031)Research Antibodies and Reagents Market Assessment, By Product, By Technology, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球研究抗體和試劑市場規模將從2023年的126.3億美元增長到2031年的218.2億美元,在2024-2031年的預測期內複合年增長率為7.08%,預計將增長到1000萬美元。
慢性病和傳染病的增加、細胞和基因治療市場的擴大、技術進步以及政府和其他相關行業對研發活動的投資增加推動了全球研究抗體和試劑市場的發展。 此外,多家領先公司、合資企業的存在以及對生物製藥和生物技術行業日益增長的興趣正在加速全球研究抗體和試劑市場的成長。
抗體和試劑廣泛應用於自體免疫疾病、癌症、傳染病等多種慢性疾病的診斷和治療。 因此,抗體和試劑市場的研究應用需求不斷增加。 人工智慧的應用等技術進步使研究人員能夠提高抗體和試劑的測試和驗證品質。 生物製藥產業和藥物開發產業等生命科學產業的發展,以及政府和相關產業投資和融資的增加是推動市場成長的因素。 此外,頻繁且持續的併購和合作協議等合作研究活動正在促進該市場的研究,並進一步推動全球研究抗體和試劑市場的發展。
慢性病盛行率增加:
由於慢性病盛行率上升,對研究抗體和試劑的需求顯著增加。 人口老化不斷加劇,促使多種慢性健康狀況的發展,包括傳染病、心血管疾病、癌症和自體免疫疾病。 這些慢性疾病需要持續的研發努力來提供診斷和創新治療。 根據世界衛生組織2023年的統計數據,慢性病是影響全世界人民最常見的疾病,每年在全球奪走4,100萬人的生命。 久坐的生活方式、不健康的飲食、肥胖以及過度吸煙和飲酒是人群慢性病患病率增加的主要危險因素。 慢性疾病缺乏完善的有效治療方法,促使人們越來越重視有效和高效的藥物以及創新的診斷和治療方法,從而促使抗體和試劑行業對先進研究的需求不斷增加。 所有這些因素都使得全球研究抗體和試劑市場蓬勃發展。
技術進步:
研究抗體和試劑技術正在迅速發展,促使市場顯著成長。 CRISPR-Cas9 和單細胞分析等技術進步正在增加需求,一些領先公司正在開發創新產品,以加速該行業的進步和成長。 例如,2023年12月,生技巨頭Cytek Biosciences, Inc.宣佈推出Cytek Orion試劑雞尾酒製備系統。 該系統是一項創新技術,可完全自動化試劑混合物的製備,簡化實驗室工作流程,提供令人滿意的結果,提高準確性並加快生產過程。
本報告調查了全球研究抗體和試劑市場,提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構以及對市場成長的影響,它總結了因素分析、案例研究。
Global research antibodies and reagents market is projected to witness a CAGR of 7.08% during the forecast period 2024-2031F, growing from USD 12.63 billion in 2023 to USD 21.82 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.
Growth in the global research antibodies and reagents market is driven by various factors, such as the increasing prevalence of chronic diseases and infectious diseases, the growing cell and gene therapy market, technological advancements, and increased investments by the government and other related industries to conduct research and development activities. Moreover, the presence of several leading players, collaborative ventures, and growing interest in the biopharmaceutical and biotechnological industry accelerates the global research antibodies and reagents market growth.
Antibodies and reagents are widely used to diagnose and treat various chronic diseases, such as autoimmune diseases, cancers, and infections. Due to this, there is increased demand for research in the antibodies and reagents market. Technological advancements such as the application of artificial intelligence (AI) enable researchers to improve the quality of antibodies and reagents testing and validation. Growth in the life science industry, such as the biopharmaceutical and drug development industries, along with increased investments and funding by the government and related industries, are the factors leading to market growth. Moreover, frequent and consistent collaboration activities such as mergers and acquisitions and partnership agreements to increase research in this market further propel the global research antibodies and reagents market.
Increasing Prevalence of Chronic Diseases
The demand for research in antibodies and reagents is increasing significantly due to the rising prevalence of chronic diseases. The increasing aging population is responsible for the onset of several chronic health conditions such as infections, cardiovascular diseases, cancer, and autoimmune diseases. These fatal chronic diseases need continuous research and development activities to bring diagnostics measures and innovative therapeutics. According to WHO 2023 statistics, chronic diseases are the most common diseases affecting people from all over the world and are responsible for 41 million deaths every year worldwide. A sedentary lifestyle, unhealthy diet, obesity, and excessive tobacco and alcohol consumption are the leading risk factors for the rising prevalence of chronic diseases among the population. The insufficient availability of successful therapies for chronic illnesses has increased emphasis on bringing effective and efficient pharmaceuticals and innovative diagnostics and treatments, consequently increasing the necessity for conducting advanced research in the antibodies and reagents industry. Due to all these factors, the global research antibodies and reagents market is flourishing.
Technological Advancements
Technological advancements in research antibodies and reagents are rapidly evolving, leading to tremendous growth in the research antibodies and reagents market. Technological advancements such as the development of CRISPR-Cas9 and single-cell analysis are increasing the demand, due to which several leading players are developing innovative product launches to accelerate advancements and growth in this industry. For instance, in December 2023 Cytek Biosciences, Inc., a leading biotechnology company, announced its latest launch "Cytek Orion", which is a reagent cocktail preparation system. It is an innovative fully automated reagent cocktailing technology that eases the laboratory workflow, leading to satisfactory results, enhancing accuracy, and speeding up the production process. This new system can mix and manage cocktail mixtures consisting of as many as 60 distinct reagent antibody conjugates. Due to these innovations and advancements, the global research antibodies and reagents market is expected to flourish in the forecasted period.
Immunohistochemistry Holds a Significant Market Share
Based on technology, immunohistochemistry holds a significant market share as it is the most preferred diagnostic test for diseases such as cancer and it is estimated that its use is significantly increasing with the increasing demand for personalized medicine. Frequent antibodies and reagents launched by the leading biopharmaceutical companies to accelerate application in immunohistochemistry technologies are leading to the faster growth of this technology. For instance, in March 2023, Aptamer Group plc, a leading provider of custom optimer selection and development services, announced the launch of a new reagent known as "Optimer-Fc", for application in automated immunohistochemistry (IHC) workflows. These innovative and potential product launches by key market players are accelerating the market growth.
Increased Application in Proteomics
Based on application, proteomics holds the maximum market share due to its technological advancements and potential in preparing personalized medicines. Due to its higher demand in the industry, several leading players are launching innovative products in this segment. For instance, in July 2023, Alfa Chemistry, a well-known chemical supplier, announced the launch of various proteomics products that will enhance life science research in the healthcare industry. These high-quality proteomics products, including staining reagents, western substrate, and TMB ELISA substrates are extensively used in protein analysis. These frequent product launches lead to escalating research activities in proteomics contributing to the overall market growth.
Asia-Pacific is Expected to be the Fastest-growing Region
Asia-Pacific is expected to be the fastest-growing region in the global research antibodies and reagents market. The rapidly increasing population and prevalence of chronic and infectious diseases in this region are accelerating the demand for increased research and development activities in developing efficient antibodies and reagents to improve drug discovery and enhance medical facilities. Asia-Pacific is an emerging market that has huge potential in the life science industry, due to which key market players are continuously developing partnership collaborations and establishing research institutes in this region to enhance research and development in this market. For instance, in September 2023, Agilent Technologies Inc. announced that it would partner with Advanced Cell Therapy and Research Institute in Singapore for three years. This partnership aims to bring innovation and advancement and enhance research studies in the field of cell and gene therapy. These collaborations within the Asia-Pacific are flourishing in the research antibodies and reagents market in this region.
Future Market Scenario (2024-2031F)
The global research antibodies and reagents market is expected to grow due to several factors. The increasing prevalence of chronic diseases worldwide is accelerating the demand for extensive research activities in the antibodies and reagents market to bring innovation and advancement in the healthcare sector. Technological advancements, such as the application of AI to ease the research process in this market, along with increased investments and funds by the government and life science industry are leading to escalating growth. Additionally, frequent collaboration activities such as partnerships to enhance research studies in this market are expected to flourish the global research antibodies and reagents market in the forecast period.
For instance, in February 2023, Bio-Techne Corporation and Cell Signaling Technology, both life science companies announced the partnership to add Simple Western validation to CST antibodies. This approach will enable researchers from different disciplines to study the molecular signaling pathways easily by using this simple Western validation platform.
Middle East and Africa
Key Players Landscape and Outlook
In the research antibodies and reagents market, several companies and research institutes, operating in antibodies and reagents research and development activities are continuously involved in collaboration activities such as developing strategic partnerships and establishing new research centers. These collaboration ventures play a crucial role in propelling the global research antibodies and reagents market's growth and expansion. These partnerships enable companies to gain informative insights regarding the latest and innovative research tools and methodology, access each other's knowledge, resources, markets, and technologies, and enhance research and development activities to bring advancement in antibodies and reagents developments. These collaborative ventures lead to innovation, expedite product development, and contribute to the enduring and robust growth of the global market.
For instance, in August 2023, Danaher Corporation, a global leader in science and technology, announced the acquisition of Abcam plc, which is a global supplier of protein consumables. This strategic acquisition will accelerate life science research and development activities to enhance diagnostics and treatment of complex diseases and propel the drug discovery process. These frequent collaborative ventures further assist in elevating the global research antibodies and reagents market.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.